as on January 21, 2026 at 11:38 pm IST
Day's Low
Day's High
0.94%
Downside
1.04%
Upside
52 Week's Low
52 Week's High
57.65%
Downside
12.19%
Upside
Check Syndax Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.8B
EPS (TTM)
-3.0705
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-123.32
Industry PE ratio
-1.6651931330472103
PEG Ratio
0EBITDA
-306.9M
Revenue (TTM)
111.3M
Profit Margin
-279.93%
Return On Equity TTM
-129.32%
Track how Syndax Pharmaceuticals P/E has moved over time to understand its valuation trends.
Syndax Pharmaceuticals in the last 5 years
Lowest (-12.15x)
March 31, 2021
Today (-123.32x)
January 21, 2026
Industry (-1.67x)
January 21, 2026
Highest (104.05x)
June 30, 2022
Today’s Price to Earnings Ratio: -123.32x
Compare market cap, revenue, PE, and other key metrics of Syndax Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.8B | -5.02% | -123.32 | -279.93% | |
| BUY | $47.4B | 113.21% | 1237.91 | 1.36% | |
| BUY | $113.2B | 85.25% | 31.06 | 31.35% | |
| NA | $37.4B | NA | 663.12 | 1.38% | |
| BUY | $77.7B | 37.03% | 17.57 | 32.13% |
The Syndax Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Syndax Pharmaceuticals investment value today
Current value as on today
₹1,54,241
Returns
₹54,241
(+54.24%)
Returns from Syndax Pharmaceuticals Stock
₹48,208 (+48.21%)
Dollar Returns*
₹6,033 (+6.03%)
Based on 19 analysts
89.47%
Buy
10.53%
Hold
0.00%
Sell
Based on 19 analysts, 89.47% of analysts recommend a 'BUY' rating for Syndax Pharmaceuticals. Average target price of $39.31
Get share price movements and forecasts by analysts on Syndax Pharmaceuticals.
What analysts predicted
48.46%UPSIDE
Target Price
$39.31
Current Price
$20.26
Analyzed by
19 Analysts
Target
$39.31
Syndax Pharmaceuticals target price $39.31, a slight upside of 48.46% compared to current price of $20.26. According to 19 analysts rating.
Search interest for Syndax Pharmaceuticals Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, SNDX stock has moved up by 33.1%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 52.8% return, outperforming this stock by 4.8%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.5% return, outperforming this stock by 49.4%
| Organisation | Syndax Pharmaceuticals |
| Headquarters | 730 Third Avenue, New York, NY, United States, 10017 |
| Industry | Health Technology |
| CEO | Mr. Michael A. Metzger M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Luke J. Albrecht J.D. | Senior VP, General Counsel & Secretary |
Dr. Peter Ordentlich B.Sc., Ph.D. | Co-Founder & Chief Scientific Officer |
Dr. Richard A. Heyman Ph.D. | Co-Founder |
Mr. Kevin McManus | Chief People Officer |
Mr. Michael A. Metzger M.B.A. | CEO & Director |
Mr. Keith Alan Goldan CPA | CFO, Treasurer & Chief Accounting Officer |
Mr. Steven Closter | Chief Commercial Officer |
Dr. Ronald M. Evans Ph.D. | Co-Founder, Advisor and Chair of Scientific Advisory Board |
Dr. Michael Downes Ph.D. | Co-Founder |
Sharon Klahre | Vice President of Investor Relations & Communications |
Syndax Pharmaceuticals share price today is $20.26 as on . Syndax Pharmaceuticals share today touched a day high of $20.47 and a low of $20.07.
Syndax Pharmaceuticals share touched a 52 week high of $22.73 on and a 52 week low of $8.58 on . Syndax Pharmaceuticals stock price today i.e. is trending at $20.26,which is 10.87% down from its 52 week high and 136.13% up from its 52 week low.
Syndax Pharmaceuticals market capitalisation is $0.00T as on .
Indian investors can start investing in Syndax Pharmaceuticals (SNDX) shares with as little as ₹91.673 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹916.73 in Syndax Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ).
Based on Syndax Pharmaceuticals share’s latest price of $20.26 as on January 21, 2026 at 11:38 pm IST, you will get 0.4936 shares of Syndax Pharmaceuticals. Learn more about
fractional shares .
Syndax Pharmaceuticals stock has given -5.02% share price returns and 24.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?